This year, specialists of the Federal State Budgetary Institution "The All-Russian State Center for Quality and Standardization of Veterinary Drugs and Feed" (FSBI "VGNKI")...
NPO Microgen, a company of the Naimbio holding, is launching on the market the first domestic human normal immunoglobulin for intravenous administration in the...
The 24th Pharmtech & Ingredients International Exposition of Equipment, Raw Materials and Technologies for Pharmaceutical Industry was held on 22-25 November 2022. It was...
The investment project will be implemented in 2023–2025. The total amount of investment is estimated to be 2.6 billion rubles.
According to Nail Nizamutdinov, General...
Binnopharm Group, a pharmaceutical company and part of Sistema, continues to expand its footprint in the CIS markets. Neobutin, an antispasmodic with prokinetic effect...
Foreign pharmaceutical companies continue to work in Russia and supply medicines to the Russian market, Executive Director of the Association of International Pharmaceutical Manufacturers...